Rui Avelar
Patrimonio netto: 2 M $ in data 31/07/2026
Patrimonio netto: 2 M $ in data 31/07/2026
Rui Avelar is currently Chief Medical Officer, Head-Research & Development at Evolus, Inc. since 2018.
Formerly, Dr. Avelar was Chief Medical Officer at AEON Biopharma Sub, Inc. from 2014 to 2018 and Chief Medical Officer at Allergan Medical Optics from 2011 to 2013.
Dr. Avelar earned a doctorate from the University of Toronto in 1989.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
EVOLUS, INC. 0,6% | 17/04/2026 | 388.999 ( 0,6% ) | 2 M $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| EVOLUS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2014 |
| Società | Posizione | Fine |
|---|---|---|
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales pharmaceuticals | Direttore Tecnico/Scientifico/R&S | 01/02/2018 |
Allergan Medical Optics | Direttore Tecnico/Scientifico/R&S | 01/12/2013 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Evolus, Inc.
Evolus, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurotoxins | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan Medical Optics | Electronic Technology |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale